Authors: SCHMIT VD FIEDLERKELLY J PHILLIPS L GRASELA TH

Citation: Vd. Schmit et al., PROSPECTIVE USE OF POPULATION PHARMACOKINETICS PHARMACODYNAMICS IN THE DEVELOPMENT OF CISATRACURIUM/, Pharmaceutical research, 14(1), 1997, pp. 91-97

Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH

Citation: Vd. Schmith et al., DOSE PROPORTIONALITY OF CISATRACURIUM, Journal of clinical pharmacology, 37(7), 1997, pp. 625-629

Authors: SCHMITH VD FIEDLERKELLY J PHILLIPS L GRASELA TH

Citation: Vd. Schmith et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PW PD) OF 51W89, A NEW NEUROMUSCULAR BLOCKING-AGENT/, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213

Authors: PHILLIPS L SCHMITH VD BRANDOM BW FIEDLERKELLY J GRASELA TH

Citation: L. Phillips et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS (PWPD) OF 51W89 IN HEALTHY PEDIATRIC-PATIENTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 213-213

Authors: SCHMITH VD FIEDLERKELLY J GRASELA TH

Citation: Vd. Schmith et al., EFFECT OF ADVANCED AGE ON THE PHARMACODYNAMICS OF DOXACURIUM - REPLY, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 360-362